Clover Health Investments, CORP /DE Form 4 insider transactions

Clover Health's CEO of Home Care, Brady Patrick Priest, disposed of Class A Common Stock shares on October 31, 2025, to cover tax obligations related to RSU vesting.

Clover Health's General Counsel, Karen Soares, had shares withheld to cover tax obligations upon the vesting of restricted stock units.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, reported the disposition of shares to cover tax obligations upon the vesting of restricted stock units.

Clover Health CEO Conrad Wai reported the disposal of Class A Common Stock to cover tax obligations related to the vesting of restricted stock units.

Clover Health's CFO, Peter J. Kuipers, disposed of 217,382 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health, sold 16,514 shares of Class A Common Stock for approximately $44,492 under a pre-arranged Rule 10b5-1 trading plan.

Clover Health's CEO of Home Care, Brady Patrick Priest, reported the automatic withholding of 48,305 shares to cover tax obligations from RSU vesting.

Clover Health Investments' CEO of Home Care, Brady Priest, had 82,778 shares withheld for tax obligations following an RSU vesting event.

Clover Health CEO Andrew Toy disposed of 242,580 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, disposed of 71,432 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Clover Health General Counsel Karen Soares reported the automatic withholding of 57,249 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Clover Health CEO Conrad Wai disposed of 92,181 Class A Common Stock shares at $2.8 each to cover tax obligations related to RSU vesting.

Jamie L. Reynoso, Clover Health's CEO of Medicare Advantage, reported the sale of 2,012 Class A Common Stock shares under a 10b5-1 plan and the withholding of 8,706 shares for tax obligations.

Clover Health CEO Andrew Toy disposed of 308,950 Class A Common Stock shares on October 1, 2025, to cover tax obligations related to RSU vesting.

Jamie L. Reynoso, Clover Health's CEO of Medicare Advantage, sold 4,914 shares of Class A Common Stock for $3.09 per share under a Rule 10b5-1 trading plan.

Clover Health's General Counsel, Karen Soares, had 6,403 shares withheld to cover tax obligations upon the vesting of restricted stock units.

Clover Health's CEO, Medicare Advantage, Jamie L. Reynoso, reported the disposition of Class A Common Stock for tax obligations related to RSU vesting.

Clover Health's CEO, Jamie L. Reynoso, filed an amended Form 4 to correct the reported number of shares withheld for tax obligations related to RSU vesting.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, reported an amended acquisition of 518,000 Class A Common Stock through restricted stock units, reflecting higher performance achievement.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, disposed of 52,967 Class A Common Stock shares to cover tax liabilities from RSU vesting.

Clover Health CEO Conrad Wai filed a Form 4 detailing a future disposition of 98,412 shares for tax obligations from RSU vesting on September 14, 2025.

Clover Health's General Counsel, Karen Soares, disposed of 7,459 Class A Common Stock shares at $2.57 each to cover tax obligations related to RSU vesting.

Clover Health Director Anna U. Loengard acquired 26,500 shares of Class A Common Stock through family IRAs, while also reporting a reduction in beneficial interest due to an ex-spouse's holdings.

Clover Health CEO Andrew Toy disposed of 85,535 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health Investments Director and 10% owner Vivek Garipalli acquired 446,980 shares of Class A Common Stock for approximately $1 million.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, sold 6,823 shares of Class A Common Stock for $2.89 per share under a pre-arranged trading plan.

Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, disposed of 29,513 shares of Class A Common Stock to cover tax obligations related to RSU vesting.

Clover Health's General Counsel, Karen Soares, amended her beneficial ownership filing to reflect the full achievement and vesting of performance-based restricted stock units.

Clover Health Investments Corp. CEO Conrad Wai reported a disposition of 27,930 Class A Common Stock shares to cover tax obligations related to RSU vesting.

Clover Health's CEO of Home Care, Brady Priest, disposed of 25,081 shares of Class A Common Stock to cover tax obligations related to RSU vesting.